Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you miss a Mounjaro dose, you can still take it within four days (96 hours) of the day it was due — after that window, skip the missed injection and resume on your usual day the following week. That four-day rule is the key practical fact. Mounjaro is a prescription-only medicine; your prescriber and the Patient Information Leaflet are the definitive guides for your individual situation, and the steps below are drawn from the licensed product information.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro works on a strict once-weekly cycle, so timing matters more than people expect. The first question to ask is simple: how many hours have passed since the day you were supposed to inject? If it is still within four days of that day, you have not missed the window. Take the dose as soon as you remember, then continue from there on your original weekly day, not four days later. The schedule does not shift; only the missed week gets corrected.
A practical way to think about it: if your usual day is Monday and you only remember on Wednesday evening, inject on Wednesday and plan for the following Monday as normal. If you are unsure whether that still falls within 96 hours, the NHS patient information for tirzepatide spells out the window clearly. Worth bookmarking if you are on treatment long-term. Our frequently asked questions page also covers practical scheduling queries.
Once more than four days have passed since the missed dose was due, the right move is to leave it. Inject on your next planned weekly day as though nothing happened. This is not about the medicine wearing off entirely (tirzepatide's half-life means some is still circulating) but about keeping the dose schedule predictable and avoiding a situation where two doses arrive too close together.
Doubling up is the one thing the licensed guidance is clear you should not do. The GI side effects that many people find manageable at a steady weekly rhythm (nausea, digestive discomfort) can become harder to tolerate if the timing bunches injections. The fuller explanation of what missing a dose actually does covers the pharmacokinetics in plain language if you want to understand the mechanism rather than just the rule.
If you have questions about the cost or logistics of keeping your supply consistent, the cost context page explains what an honest Mounjaro price includes and why supply-chain reliability matters.
A missed week here and there, handled using the 96-hour rule, rarely derails treatment. Gaps of two weeks or more are different. After an extended break, the body can respond to the next injection with a stronger reaction than usual, some people notice nausea returning in a way that felt like the very early weeks of treatment again. This is not dangerous, but it can be uncomfortable and unsettling.
If you have been off treatment for around a month or longer, speak to your prescriber before simply picking up where you left off. Depending on how long the break was and what dose you were on, they may recommend stepping back to an earlier dose temporarily. The prescribing team at nume reviews every repeat order clinically, which means this kind of gap is exactly the sort of thing a prescriber catches before it becomes a problem. Our page on longer-term treatment at 15mg is useful context if you are thinking about what sustained treatment looks like overall.
It is also worth knowing that the titration schedule (starting at 2.5mg and moving up through the dose steps) exists precisely because the body needs time to adjust. If a long gap means restarting at a lower dose, that is the schedule doing its job, not a setback.
The first few months of treatment are when most people are still moving through the 2.5mg and 5mg phases. Missing doses at this stage can complicate the picture in a specific way: some people interpret a missed week as the right moment to jump ahead on dose, reasoning that the next injection will somehow compensate. It does not work that way, and it is not safe to self-adjust the schedule. How long you stay at each dose is a clinical decision, not a calendar one. The guidance on how long 2.5mg typically lasts and the related question of when to move on from the starter dose explain why that early phase has a job to do, regardless of whether a week was missed.
One thing our prescribers hear from patients fairly regularly: the temptation to inject on a Sunday evening rather than Monday morning because the week got busy. That is fine. The weekly day can be shifted, but only by a few days at a time, and your prescriber should know. The practical steps for a missed Mounjaro dose page goes into the specifics of day-switching versus genuine missed doses. And if you are considering whether your current dose is doing what it should, a read of the 5mg dose overview or the broader Mounjaro treatment guide may help frame the conversation with your prescriber. The MHRA Drug Safety Updates index is also worth knowing about, it is where the regulator publishes communications about medicines like tirzepatide as new information emerges.
If you are thinking about starting treatment or are currently on it with gaps causing concern, checking your eligibility with our prescribers is a straightforward next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.